Fabino Enterprises Ltd (FABINO) — shareholding pattern, promoter holding, financials and share price
About Fabino Enterprises Ltd (FABINO)
Fabino Enterprises Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as FABINO and on the BSE under scrip code 543444. Its ISIN is INE0DRT01018.
Incorporated in 2011, Fabino Enterprises manufactures, markets, trades, and does packing of pharmaceutical and other wellness focused consumer products [1]
Fabino Enterprises Limited is primarily engaged in the manufacturing and marketing of pharmaceutical, allopathic, herbal, and veterinary products under its own brand names, targeting both domestic and international markets.
Fabino's operations include a manufacturing plant in Sonipat, Haryana, and it markets over 70 products in the domestic market, along with a diverse portfolio of FMCG products for international markets.
Listed peers in Pharmaceuticals: Vivanza Biosciences Ltd, Ganga Pharmaceuticals Ltd, Decipher Labs Ltd, Brawn Biotech Ltd, Shyama Computronics and Services Ltd, Triochem Products Ltd.
Valuation & Returns
At ₹20.3 a share, Fabino Enterprises Ltd (FABINO) was valued at a price-to-book of 1.17x on a book value of ₹17.38 per share. Solomo computes return on equity of -15.32% and return on capital employed of -11.5% from filed results.
- Industry P/E
- 36.41x
- P/B
- 1.17x
- Book value / share
- ₹17.38
- ROE
- -15.32%
- ROCE
- -11.5%
- ROA
- -2.53%
- Debt / equity
- 0.45x
- Dividend yield
- 0%
- EBITDA margin
- -2.4%
- 52-week range
- ₹13.01 – ₹30.8
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Fabino Enterprises Ltd (FABINO) reported revenue of ₹20.84 crore, net profit of ₹-0.56 crore and earnings per share of ₹-2.67. That compares with revenue of ₹17.98 crore and net profit of ₹0.06 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹14.21 crore and net profit ₹-0.37 crore (consolidated).
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue (₹ cr) | 3.36 | 21.01 | 17.98 | 20.84 |
| Net profit (₹ cr) | 0.01 | 0.04 | 0.06 | -0.56 |
| EPS (₹) | 0.05 | 0.19 | 0.29 | -2.67 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 19.13% | 62.53% | -14.42% |
| Profit growth | 13.87% | 41.03% | 50.00% |
| Stock price CAGR | - | -11% | -22% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 56.82% of Fabino Enterprises Ltd (FABINO). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2022.
Largest disclosed public shareholders in Mar 2026: VISHAL MAHESH WAGHELA 4%, VENKATESHWARA INDUSTRIAL PROMOTION CO LIMITED 3.14%, S K GROWTH FUND PVT LTD 2.29%, HUF 2.29%, EMRALD COMMERCIAL LIMITED 1.71%, CHIRAGKUMAR VALANI 1.43%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 56.82% | - | - | - | 43.18% |
| Sep 2025 | 56.82% | - | - | - | 43.18% |
| Mar 2025 | 56.82% | - | - | - | 43.18% |
| Sep 2024 | 56.82% | - | - | - | 43.18% |
| Mar 2024 | 56.82% | - | - | - | 43.18% |
| Sep 2023 | 56.82% | - | - | - | 43.18% |
| Mar 2023 | 56.82% | - | - | - | 43.18% |
| Sep 2022 | 56.82% | - | - | - | 43.18% |